Auxogyn is dedicated to advancing women’s reproductive health through diagnostic technologies that generate information to be used by physicians and their patients in making treatment decisions. Our commitment is to instill clinical rigor and discipline to bring new innovation to market through science and technology. Through an inter-disciplinarian approach we take scientific discovery and develop a prognostic assay that is validated first through independent data followed by multiple-site study clinical validation. We pursue a regulatory path to assure our technologies are safe and effective and meet stringent regulatory standards.
Auxogyn’s history brings this philosophy to life, from its foundation on the scientific discovery of Stanford research to FDA clearance. Following the interdisciplinary approach and thorough process through to market, Auxogyn demonstrates its commitment to improving women’s reproductive health and quality of life.